scholarly article | Q13442814 |
P356 | DOI | 10.1093/HUMREP/16.3.561 |
P698 | PubMed publication ID | 11228229 |
P2093 | author name string | T Tanaka | |
M Sasaki | |||
S Igarashi | |||
H Ota | |||
P433 | issue | 3 | |
P921 | main subject | endometriosis | Q205764 |
P304 | page(s) | 561-566 | |
P577 | publication date | 2001-03-01 | |
P1433 | published in | Human Reproduction | Q5937357 |
P1476 | title | Distribution of cyclooxygenase-2 in eutopic and ectopic endometrium in endometriosis and adenomyosis | |
P478 | volume | 16 |
Q34008026 | A conditionally replicative adenovirus, CRAd-S-pK7, can target endometriosis with a cell-killing effect |
Q42380795 | Abnormal Expression of Prostaglandins E2 and F2α Receptors and Transporters in Patients with Endometriosis |
Q26786756 | Adenomyosis and its impact on women fertility |
Q35067602 | Anti-inflammatory, antiangiogenic, and apoptosis-inducing activity of DLBS1442, a bioactive fraction of Phaleria macrocarpa, in a RL95-2 cell line as a molecular model of endometriosis. |
Q37326252 | Anti-platelet therapy holds promises in treating adenomyosis: experimental evidence |
Q33903608 | Autotaxin-lysophosphatidic acid-LPA3 signaling at the embryo-epithelial boundary controls decidualization pathways |
Q91712604 | Celecoxib, a selective COX-2 inhibitor, markedly reduced the severity of tamoxifen-induced adenomyosis in a murine model |
Q47121869 | Complications and outcomes of pregnant women with adenomyosis in Japan |
Q35581225 | Cyclooxygenase enzymes and prostaglandins in pathology of the endometrium. |
Q35547033 | Cyclooxygenase enzymes and prostaglandins in reproductive tract physiology and pathology. |
Q92099145 | Cyclooxygenase-2 in Endometriosis |
Q36341296 | DNA hypomethylation of the COX-2 gene promoter is associated with up-regulation of its mRNA expression in eutopic endometrium of endometriosis |
Q36722241 | DNA methylation in endometriosis (Review). |
Q37061095 | Deficiency of immunophilin FKBP52 promotes endometriosis |
Q48690673 | Effects of prostaglandin E2 and vascular endothelial growth factor on sperm might lead to endometriosis-associated infertility |
Q24185846 | Endometrial biomarkers for the non-invasive diagnosis of endometriosis |
Q39365130 | Endometrial receptivity in the eutopic endometrium of women with endometriosis: it is affected, and let me show you why. |
Q36855660 | Endometrial-peritoneal interactions during endometriotic lesion establishment |
Q49884536 | Endometriosis and endometriosis-associated cancers: new insights into the molecular mechanisms of ovarian cancer development |
Q35668144 | Endometriosis: alternative methods of medical treatment. |
Q98613567 | Endometritis in the bitch: Immunohistochemical localization of cyclooxygenase 2 |
Q36194043 | Euterpe oleracea Extract (Açaí) Is a Promising Novel Pharmacological Therapeutic Treatment for Experimental Endometriosis |
Q92184572 | Eutopic endometrium from patients with endometriosis modulates the expression of CD36 and SIRP-α in peritoneal macrophages |
Q46567254 | Expression of cyclooxygenase-2 (COX-2), receptors for estrogen (ER), and progesterone (PR), p53, ki67, and neu protein in endometrial cancer. |
Q21203690 | Immunohistochemical analysis of an ectopic endometriosis in the uterine round ligament |
Q77218175 | Increased expression of cyclooxygenase-2 in local lesions of endometriosis patients |
Q36509755 | Inflammatory status influences aromatase and steroid receptor expression in endometriosis. |
Q33597181 | Inhibition of CD36-dependent phagocytosis by prostaglandin E2 contributes to the development of endometriosis |
Q35107985 | Lipoxin A₄ prevents the progression of de novo and established endometriosis in a mouse model by attenuating prostaglandin E₂ production and estrogen signaling |
Q34362219 | Macrophage migration inhibitory factor is involved in ectopic endometrial tissue growth and peritoneal-endometrial tissue interaction in vivo: a plausible link to endometriosis development |
Q53239739 | Medical Management of Endometriosis. |
Q40049589 | NSAID resistance in dysmenorrhea: epidemiology, causes, and treatment. |
Q35108926 | Noninvasive diagnosis of endometriosis: the role of imaging and markers |
Q34636424 | Oxidative stress and peritoneal endometriosis |
Q33936661 | Possible Loss of GABAergic Inhibition in Mice With Induced Adenomyosis and Treatment With Epigallocatechin-3-Gallate Attenuates the Loss With Improved Hyperalgesia |
Q26767444 | Recent advances in the understanding of endometriosis: the role of inflammatory mediators in disease pathogenesis and treatment |
Q90027519 | Role of angiogenesis in adenomyosis-associated abnormal uterine bleeding and subfertility: a systematic review |
Q33642212 | Selective inhibition of prostaglandin E2 receptors EP2 and EP4 induces apoptosis of human endometriotic cells through suppression of ERK1/2, AKT, NFkappaB, and beta-catenin pathways and activation of intrinsic apoptotic mechanisms. |
Q33581564 | Selective inhibition of prostaglandin E2 receptors EP2 and EP4 inhibits adhesion of human endometriotic epithelial and stromal cells through suppression of integrin-mediated mechanisms |
Q36853935 | Surgical removal of endometriotic lesions alters local and systemic proinflammatory cytokines in endometriosis patients |
Q36199231 | Telemetric assessment of referred vaginal hyperalgesia and the effect of indomethacin in a rat model of endometriosis |
Q38192902 | The peritoneum--an important factor for pathogenesis and pain generation in endometriosis |
Q24656185 | Up-regulation of cyclooxygenase-2 expression and prostaglandin E2 production in human endometriotic cells by macrophage migration inhibitory factor: involvement of novel kinase signaling pathways |
Q43990128 | Up-regulation of cyclooxygenase-2 expression and prostaglandin synthesis in endometrial stromal cells by malignant endometrial epithelial cells. A paracrine effect mediated by prostaglandin E2 and nuclear factor-kappa B. |
Q81442157 | [Adenomyosis: update on a frequent but difficult diagnosis] |
Q52847220 | [Endometriosis : An often unrecognized pain disorder]. |
Search more.